首页> 外文会议>International Conference on Algorithms for Computational Biology >Utilize Imputation Method and Meta-analysis to Identify DNA-Methylation-Mediated microRNAs in Ovarian Cancer
【24h】

Utilize Imputation Method and Meta-analysis to Identify DNA-Methylation-Mediated microRNAs in Ovarian Cancer

机译:利用透明方法和荟萃分析来鉴定卵巢癌中的DNA-甲基化介导的MicroRNA

获取原文

摘要

Both epigenetics and genetic alterations are associated with cancer formation. Identification of prognostic biomarkers, DNA-methylation-mediated miRNAs, is an important step towards developing therapeutic treatment of cancer. Ovarian cancer is one of the most lethal cancers among the females, it was selected for the present study. The TCGA database provides large volume of data for cancer study, which is useful if one can combine different batches of datasets; hence, higher confident results can be obtained. There are several issues arise in data integration, i.e., missing data problem, data heterogeneity problem and the need of construct an automatic platform to reduce human intervention. Method. Both the normal and ovarian tumor datasets were obtained from the TCGA database. To interpolate the missing methylation values, we employed the KNN imputation method. Simulation tests were performed to obtain the optimal k value. We utilized meta-analysis to minimize the heterogeneity problem and derived statistical significant DNA methylation-mediated-miRNA events. Finally, a semi-automatic pipeline was constructed to facilitate the imputation and meta-analysis studies; thus, identify potential epigenetic biomarkers in a more efficient manner. Results. Both epigenetic- and TF-mediated effects were examined, which allow us to remove false positive events. The methylation-mediated-miRNA pairs identified by our platform are in-line with literature studies. Conclusion. We have demonstrated that our imputation and meta-analysis pipeline led to better performance and efficiency in detecting methylation-mediated-miRNA pairs. Furthermore, this study reveals the association between aberrant DNA methylation and alternated miRNA expression, which contributes to better knowledge of the role of epigenetics regulation in ovarian cancer formation.
机译:表观生物学和遗传改变都与癌症形成有关。鉴定预后生物标志物,DNA-甲基化介导的miRNA是朝着发育癌症治疗治疗的重要步骤。卵巢癌是女性中最致命的癌症之一,它被选择为目前的研究。 TCGA数据库为癌症研究提供大量数据,如果可以组合不同批次的数据集,这是有用的;因此,可以获得更高的自信结果。数据集成有几个问题,即缺少数据问题,数据异质性问题以及构建自动平台的需要,以减少人为干预。方法。从TCGA数据库获得正常和卵巢肿瘤数据集。为了内插缺失的甲基化值,我们采用了KNN归咎地方法。进行仿真测试以获得最佳k值。我们利用了Meta分析以最小化异质性问题和衍生统计显着的DNA甲基化介导的-MiRNA事件。最后,构建了半自动管道,以促进估算和荟萃分析研究;因此,以更有效的方式识别潜在的表观遗传生物标志物。结果。检查表观遗传和TF介导的效果,允许我们去除假阳性事件。我们的平台鉴定的甲基化介导的-MiRNA对与文献研究一致。结论。我们已经证明,我们的归纳和荟萃分析管线导致检测甲基化介导的-MiRNA对的性能和效率。此外,该研究揭示了异常DNA甲基化和交替miRNA表达之间的关联,这有助于更好地了解表观生物学调节在卵巢癌形成中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号